Invention Grant
- Patent Title: ZAG-derived peptide and use thereof
-
Application No.: US16652045Application Date: 2018-09-28
-
Publication No.: US11213567B2Publication Date: 2022-01-04
- Inventor: Eun Seong Lee , Hyung Gu Kim , Whan Chul Lee , Kee Won Lee
- Applicant: L&C Bio Co., LTD.
- Applicant Address: KR Seongnam-si
- Assignee: L&C Bio Co., LTD.
- Current Assignee: L&C Bio Co., LTD.
- Current Assignee Address: KR Seongnam-si
- Priority: KR10-2017-0127139 20170929
- International Application: PCT/KR2018/011593 WO 20180928
- International Announcement: WO2019/066590 WO 20190404
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K38/10 ; A61K38/08 ; A61K38/16 ; A61K8/64 ; A61P17/10 ; A61Q19/00
Abstract:
A zinc-alpha-2-glycoprotein (ZAG) protein-derived peptide according to the present invention shows an expression reducing effect of various immune factors shown in acute or chronic atopic dermatitis, and has a decreased immune response and decreased IgE expression and thus may be used to prevent, treat or improve xeroderma or an abnormal skin barrier function such as atopic dermatitis, an allergic disease or inflammation.
Public/Granted literature
- US20200246428A1 ZAG-DERIVED PEPTIDE AND USE THEREOF Public/Granted day:2020-08-06
Information query
IPC分类:
